Skip to Main Content

Paper Details

Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events.
EBioMedicine
3
2023
CKD, Lidgard, Patients, R01, Sphingolipid, Sphingolipids, cardiovascular disease, ceramide, ceramides, chronic kidney disease, fatty acids, heart failure, ischemic stroke, kidney disease, myocardial infarction, participants, patients, plasma, sphingolipids, sphingomyelin, sphingomyelins, women
Author NameAffiliation
Nisha BansalUniversity of Washington
Andrew N HoofnagleUniversity of Washington
Michael G ShlipakSan Francisco Veterans Affairs Healthcare System and University of California San Francisco
David S SiscovickNew York Academy of Medicine
Jason G UmansGeorgetown University
  • 1 - 5

Datasets

Release 1.2